# GLP-1 digestive changes and the gut microbiome

Bloating or bowel changes do not reveal what your gut bacteria are doing. Known medication effects and early microbiome research answer different questions.

Canonical: https://velri.co/blog/glp1-gut-microbiome-digestion-month-two-first-timer
Publisher: Velri (https://velri.co/about)
Published: 2026-07-07
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

Semaglutide and tirzepatide affect appetite and stomach emptying. Nausea, constipation and diarrhea are among their recognized side effects. Researchers are also studying how treatment may affect the gut microbiome. [1][2]

Microbiome research asks a different question: whether the communities of organisms in the gut change with treatment, and what those changes might mean.

## Digestion involves more than bacteria

Gut bacteria help break down food, but digestion also depends on muscles, nerves, hormones and digestive juices. The movement of food through the tract and the absorption of water contribute to the final bowel pattern. [3]

That is why bloating or a change in stool cannot identify a particular bacterial shift. The symptom describes an experience, not a microbiome measurement. [3]

## What does the human research show?

A small study followed 15 people in China with type 2 diabetes whose blood sugar was poorly controlled on existing treatment. Researchers compared stool and blood samples before and after 12 weeks of semaglutide and observed changes in bacterial composition and metabolic measurements. [4]

With only 15 participants and a before-and-after design, the study could identify associations but could not establish whether bacterial changes caused the metabolic improvements. [4]

## What is more immediately useful?

A symptom review considers when the change began, the actual medication, food and fluid intake, other medicines and the bowel pattern. Changes in eating, insufficient fluid or fiber, and some supplements can contribute to constipation alongside the medication. [1][2][5]

Persistent digestive problems deserve assessment on those terms. Constant abdominal pain, vomiting, inability to pass gas, fever or blood in the stool require prompt medical attention. [5]

## Sources
[1] DailyMed - WEGOVY- semaglutide injection, solution
WEGOVY- semaglutide tablet (2026). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
[2] DailyMed - ZEPBOUND- tirzepatide injection, solution
ZEPBOUND- tirzepatide injection, solution
ZEPBOUND KWIKPEN- tirzepatide injection, solution (2026). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
[3] Your Digestive System & How it Works - NIDDK (2017). https://www.niddk.nih.gov/health-information/digestive-diseases/digestive-system-how-it-works
[4] The Effect of Semaglutide on Gut Microbiota in Chinese Patients with Type 2 Diabetes Poorly Controlled by Metformin. (2025). https://pubmed.ncbi.nlm.nih.gov/41132642/
[5] Symptoms & Causes of Constipation - NIDDK (2018). https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/symptoms-causes

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support